A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)
Clinical trial NCT00819585 · COMPLETED
Trial details
- NCT number
- NCT00819585
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2010-08-01
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.